Spin-off and sale

Discussion in 'Shire' started by anonymous, Oct 13, 2017 at 11:46 AM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    Insecure boys get angry when mommy corrects them. Stock hitting the bottom, activist shareholders talking to the board- oh yeah -good times. Ask your mommy to read the paper to you this morning.
     

  2. anonymous

    anonymous Guest

    Didnt realize mommy was correcting me. Just some dick mouthing off that generic Restasis is the end of the world when you have a product that works twice as fast. Must b nice living in a world with one competitor and no generics....tough sale
     
  3. anonymous

    anonymous Guest

    When people say sales reps are idiots and interchangeable you two (assuming this is a basic and forth) prove the point. First, since there is no head to head data vs Restasis, so If jerk #2 is saying our drug works twice as fast that would be shall we say non-compliant. And the biggest generic threat for us is the one to Vyvanse which our “leaders”created by trying to market Mydayis. That goes off patent before Vyvanse - so something you children have in common with FO- you are all jerks.